{"entity":{"id":"nct02468024","kind":"trial","name":"JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer","aka":["STABLE-MATES"],"tldr":"A phase 3 trial in lung cancer, run by University of Texas Southwestern Medical Center, now recruiting.","summary":"JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer is a phase 3, randomised interventional study registered as NCT02468024 by University of Texas Southwestern Medical Center, with a registry enrolment figure of 272 participants, started 2015-07 and due to reach its primary completion in 2028-12. Interventions recorded: Lung Surgery; Radiation therapy. Conditions listed: Non-Small Cell Lung Cancer. Primary outcome: overall survival. Lung eligibility wording from the registry: \"3 Radiographic findings consistent with non-small cell lung cancer, including lesions with ground glass opacities with a solid component of 50% or greater\". Sites: Australia, Canada, United Kingdom, United States. United Kingdom sites listed: 1. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT02468024","url":"https://clinicaltrials.gov/study/NCT02468024"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["resectable-nsclc"],"sections":[],"technologies":["sbrt"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["UK sites (registry): The James Cook University Hospital (Middlesbrough)."],"nct":"NCT02468024","phase":"3","setting":"JoLT-Ca A Randomized Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients With Stage I Non-Small Cell Lung Cancer (NSCLC), The STABLE-MATES Trial","sponsor":"University of Texas Southwestern Medical Center","enrolled":272,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02468024/","neighbours":{"cancer":[{"id":"resectable-nsclc","kind":"cancer","name":"Resectable stage I to III non-small-cell lung cancer","route":"/cancers/resectable-nsclc/"}],"technology":[{"id":"sbrt","kind":"technology","name":"SBRT / SABR (stereotactic radiotherapy)","route":"/technologies/sbrt/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}